tbResList Print — Sper Spermidine

Filters: qv=386, qv2=%, rfv=%

Product

Sper Spermidine
Description: <b>Spermidine</b> : Polyamine (natural small molecule)<br>

Sources: Found in foods like wheat germ, soybeans, mushrooms, aged cheese, and fermented foods. Typical dietary intake is ~5–20 mg/day.Top food sources = wheat germ > soybeans > aged cheddar > mushrooms > rice bran/legumes.<br>
<br>
Ripening / fermentation: especially in aged or fermented foods like cheese, where spermidine and other polyamines can rise during ripening because microbial activity and protein breakdown contribute to amine formation. That is one reason aged cheeses can rank unusually high.<br>
Cooking: boiling and grilling significantly reduced polyamine content in many foods, whereas microwave and sous-vide tended to preserve more.<br>
<br>
Primary Actions: Autophagy induction, mild ROS modulation, epigenetic regulation, and modulation of polyamine metabolism.<br>
<pre>
Pathway Effect of Spermidine
Autophagy (ATG genes) ↑ Induction, Beclin-1 activation
mTORC1 signaling ↓ Inhibition, promotes catabolic metabolism
p53/p21 Modulation via epigenetic changes
Polyamine metabolism Supports or stresses proliferating cells
ROS / redox balance Mild modulation; sensitizes cancer cells to ROS stress
</pre>
Context-dependent risk: High spermidine levels might support tumor growth in polyamine-addicted cancers; dose, timing, and tumor type matter.<br>
<br>
Chemo interaction: Generally compatible; not expected to block ROS-dependent therapy at oral doses.<br>
<br>
Spermidine, a biogenic polyamine that declines along with aging, shows promise in restoring antitumor immunity by enhancing mitochondrial fatty acid oxidation (FAO)<br>
<br>

Spermidine — Cancer vs Normal Cell Effects
<table border="1" cellspacing="0" cellpadding="4">
<tr>
<th>Rank</th>
<th>Pathway / Axis</th>
<th>Cancer Cells</th>
<th>Normal Cells</th>
<th>Label</th>
<th>Primary Interpretation</th>
<th>Notes</th>
</tr>

<tr>
<td>1</td>
<td>Autophagy induction (ATG program)</td>
<td>↑ autophagy → metabolic stress, growth restraint</td>
<td>↑ autophagy → cytoprotection, homeostasis</td>
<td>Driver</td>
<td>Autophagy-first mechanism</td>
<td>Spermidine robustly induces autophagy independent of mTOR inhibition; cancer cells are more vulnerable to enforced catabolism</td>
</tr>

<tr>
<td>2</td>
<td>Epigenetic regulation (histone acetylation)</td>
<td>↓ histone acetylation (via HAT inhibition)</td>
<td>↓ acetylation (adaptive)</td>
<td>Driver</td>
<td>Chromatin-mediated transcriptional reprogramming</td>
<td>Spermidine inhibits histone acetyltransferase activity, promoting a pro-autophagic, anti-proliferative transcriptional state</td>
</tr>

<tr>
<td>3</td>
<td>Polyamine metabolism / homeostasis</td>
<td>Disrupted polyamine balance</td>
<td>Homeostatic buffering</td>
<td>Driver</td>
<td>Metabolic vulnerability</td>
<td>Cancer cells are highly dependent on polyamine flux; spermidine perturbs this balance</td>
</tr>

<tr>
<td>4</td>
<td>AMPK / mTOR nutrient-sensing axis</td>
<td>↑ AMPK; ↓ mTOR signaling</td>
<td>↑ AMPK (adaptive)</td>
<td>Secondary</td>
<td>Catabolic pressure</td>
<td>Energy-sensing pathways reinforce autophagy and growth suppression</td>
</tr>

<tr>
<td>5</td>
<td>Mitochondrial function / bioenergetics</td>
<td>↓ metabolic flexibility</td>
<td>↑ mitochondrial efficiency</td>
<td>Secondary</td>
<td>Energy stress vs optimization</td>
<td>Autophagy-driven mitochondrial turnover stresses tumor bioenergetics while benefiting normal cells</td>
</tr>

<tr>
<td>6</td>
<td>Reactive oxygen species (ROS)</td>
<td>↑ ROS (secondary, stress-linked)</td>
<td>↓ ROS</td>
<td>Secondary</td>
<td>Metabolism-linked redox shift</td>
<td>ROS changes arise indirectly from autophagy and mitochondrial remodeling, not direct redox chemistry</td>
</tr>

<tr>
<td>7</td>
<td>NRF2 antioxidant response</td>
<td>↑ NRF2 (adaptive, secondary)</td>
<td>↑ NRF2 (protective)</td>
<td>Adaptive</td>
<td>Redox homeostasis reinforcement</td>
<td>NRF2 activation reflects compensatory antioxidant signaling rather than a cytotoxic mechanism</td>
</tr>

<tr>
<td>8</td>
<td>Cell cycle / proliferation</td>
<td>↓ proliferation / ↑ arrest</td>
<td>↔ spared</td>
<td>Phenotypic</td>
<td>Cytostatic growth limitation</td>
<td>Growth inhibition reflects sustained autophagy and epigenetic effects</td>
</tr>

<tr>
<td>9</td>
<td>Apoptosis sensitivity</td>
<td>↑ sensitivity to apoptosis (context-dependent)</td>
<td>↓ apoptosis</td>
<td>Phenotypic</td>
<td>Threshold-dependent cell death</td>
<td>Apoptosis occurs when catabolic stress exceeds adaptive capacity</td>
</tr>

</table>

Pathway results for Effect on Cancer / Diseased Cells

Redox & Oxidative Stress

Ferroptosis↑, 1,   H2O2↑, 1,   HO-1↑, 1,   Iron↑, 1,   lipid-P↑, 1,   NRF2↑, 1,   mt-ROS↑, 1,   ROS↑, 3,  

Mitochondria & Bioenergetics

MMP↓, 3,  

Core Metabolism/Glycolysis

ACLY↓, 1,   CRM↑, 2,   CRM↝, 1,  

Cell Death

Apoptosis↑, 4,   Bcl-2↓, 1,   Cyt‑c↑, 3,   Ferroptosis↑, 1,   TumCD↑, 1,  

Transcription & Epigenetics

other↓, 1,  

Autophagy & Lysosomes

ATG5↑, 1,   Beclin-1↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3B-II↑, 1,   TumAuto↑, 5,  

Cell Cycle & Senescence

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State

EP300↓, 1,   TumCG↓, 1,   TumCG⇅, 1,  

Migration

TumCP↓, 1,  

Immune & Inflammatory Signaling

Inflam↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 1,   BioAv↓, 1,   ChemoSen↑, 2,   eff↑, 5,   eff↓, 2,  

Clinical Biomarkers

GutMicro↝, 2,  

Functional Outcomes

AntiAge↑, 1,   AntiCan↑, 3,   AntiTum↑, 3,   cardioP↑, 2,   cognitive↑, 1,   memory↑, 1,   OS↑, 1,   Risk↓, 1,  
Total Targets: 43

Pathway results for Effect on Normal Cells

Redox & Oxidative Stress

antiOx↑, 1,   ROS↑, 1,   ROS↓, 1,  

Mitochondria & Bioenergetics

Insulin↓, 1,   mitResp↑, 1,  

Core Metabolism/Glycolysis

AMPK↑, 1,   CRM↑, 1,   mt-FAO↑, 1,   Glycolysis↓, 1,   SIRT1↑, 1,  

Transcription & Epigenetics

HATs↓, 1,  

Autophagy & Lysosomes

p62↓, 1,  

Proliferation, Differentiation & Cell State

EP300↓, 1,   mTOR↓, 1,   mTORC1↓, 1,  

Immune & Inflammatory Signaling

Inflam↓, 2,   TNF-α↓, 1,  

Protein Aggregation

Aβ↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 1,   Dose⇅, 1,   Dose↝, 5,   Dose↑, 2,  

Clinical Biomarkers

BP↓, 1,  

Functional Outcomes

AntiAge↑, 3,   cardioP↑, 1,   cognitive↑, 2,   cognitive↝, 1,   memory↑, 1,   neuroP↑, 2,   OS↑, 1,   Weight↓, 1,  
Total Targets: 31

Research papers

Year Title Authors PMID Link Flag
2021Caloric Restriction Mimetics in Nutrition and Clinical TrialsSebastian J HoferPMC8450594https://pmc.ncbi.nlm.nih.gov/articles/PMC8450594/0
2019Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic PotentialFrank Madeohttps://www.cell.com/cell-metabolism/fulltext/S1550-4131%2819%2930018-X0
2017Caloric Restriction Mimetics Enhance Anticancer ImmunosurveillanceFederico PietrocolaPMC5715805https://pmc.ncbi.nlm.nih.gov/articles/PMC5715805/0
2025Spermidine inactivates proteasome activity and enhances ferroptosis in prostate cancerDan Fenghttps://www.sciencedirect.com/science/article/pii/S22113835250010050
2025Application of Spermidine in Cancer Research Models: Notes and ProtocolsBenchChem Technical Support Teamhttps://pdf.benchchem.com/1203/Application_of_Spermidine_in_Cancer_Research_Models_Notes_and_Protocols.pdf0
2025Spermidine potentiates anti-tumor immune responses and immunotherapy sensitivity in breast cancerXinyu Yanghttps://www.jcancer.org/v16p3684.htm0
2024Chemoproteomic Identification of Spermidine-Binding Proteins and Antitumor-Immunity ActivatorsVaibhav Pal Singhhttps://pubs.acs.org/doi/10.1021/jacs.3c146150
2024Spermidine – an old molecule with a new age-defying immune functionKenji Chamotohttps://www.cell.com/trends/cell-biology/abstract/S0962-8924(23)00166-60
2023Spermidine as a promising anticancer agent: Recent advances and newer insights on its molecular mechanismsParteek PrasherPMC10117651https://pmc.ncbi.nlm.nih.gov/articles/PMC10117651/0
2023The Effect of Spermidine Supplementation on Cognitive Function in Adults: A Mini-ReviewVirginia Zaramahttps://journal.ppcr.org/index.php/ppcrjournal/article/download/284/273/58400
2023Spermidine as a promising anticancer agent: Recent advances and newer insights on its molecular mechanismsParteek Prasherhttps://www.frontiersin.org/journals/chemistry/articles/10.3389/fchem.2023.1164477/pdf0
2020The positive effect of spermidine in older adults suffering from dementia : First results of a 3-month trialThomas Pekarhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8116233/0
2020Spermidine as a target for cancer therapyJingjing Fanhttps://www.sciencedirect.com/science/article/abs/pii/S10436618203125120
2018The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trialMiranka Wirth30388439https://pubmed.ncbi.nlm.nih.gov/30388439/0
2018Cardioprotection and lifespan extension by the natural polyamine spermidineTobias EisenbergPMC5806691https://pmc.ncbi.nlm.nih.gov/articles/PMC5806691/0
2018Spermidine reduces cancer-related mortality in humansFederico PietrocolaPMC6333461https://pmc.ncbi.nlm.nih.gov/articles/PMC6333461/0
2014Spermidine induces autophagy by inhibiting the acetyltransferase EP300F PietrocolaPMC4326581https://pmc.ncbi.nlm.nih.gov/articles/PMC4326581/0
2009Long-term oral polyamine intake increases blood polyamine concentrationsKuniyasu Soda19763038https://pubmed.ncbi.nlm.nih.gov/19763038/0